Paragonimus infection medical therapy: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
Line 24: | Line 24: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 18:37, 18 September 2017
Paragonimus infection Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Paragonimus infection medical therapy On the Web |
American Roentgen Ray Society Images of Paragonimus infection medical therapy |
Risk calculators and risk factors for Paragonimus infection medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Praziquantel is the drug of choice to treat paragonimiasis. Bithionol is an alternative drug for treatment of this disease.
Medical Therapy
Praziquantel is the drug of choice: adult or pediatric dosage, 25 mg/kg given orally 3 times per day for 2 consecutive days.
Alternatives: Triclabendazole (not available in the U.S.), adult or pediatric dosage, 10 mg/kg orally once or twice; or Bithionol: adult or pediatric dosage, 30-50 mg/kg on alternate days for 10-15 doses.
For cerebral disease, a short course of corticosteroids may be given with the praziquantel to help reduce the inflammatory response around dying flukes.
Antimicrobial Regimen
- Preferred regimen (1): Praziquantel 25 mg/kg PO tid for 3 days[1]
- Preferred regimen (2): Triclabendazole 10 mg/kg PO qd or bid
- Alternative regimen (1): Bithinol 30-50mg/kg PO on alternate days for 10-15 doses
- Alternative regimen (2): Niclosamide 2mg/kg PO single dose